Found Health logo
Provider review · checked 29 August 2026

Found Health review

Visit Found Health
2comparison programs tracked
$169–$359published monthly range
$120/molargest tracked plan saving
Medication includedcompounded plan basis
Published listings

Found Health programs and current prices

2 comparison programs and 1 additional listings, checked 29 August 2026.

View full provider profile
Found Health programs and published prices
TreatmentCurrent monthly priceFormatVisit
Semaglutide$289a month after a first month at $99Weekly injectionVisit
Tirzepatide$359a month after a first month at $149Weekly injectionVisit
Other
Brand-name GLP-1 accessPrice after insurance or cash-pay reviewProvider-selectedVisit

Verdict: best for integrated weight-management support

Found Health is best for someone who wants a compounded GLP-1 program bundled with clinician access, coaching, lifestyle tools, and a member community. It is not the cleanest choice for a shopper who wants only a prescription at the shortest possible commitment, because its lowest effective rates depend on plan terms and its broader program is part of the product.

Found also facilitates access to brand-name prescriptions, but the brand drug and related lab costs are not automatically included in the compounded-plan total. Compare the correct pathway: compounded cash pay against other medication-included plans, or brand access against programs that provide insurance and prior-authorization support.

Found's current compounded GLP-1 prices

The dynamic rows below compare Found's medication-included compounded semaglutide and tirzepatide records. Introductory, continuing, and longer-plan effective amounts remain separate in the catalog.

  • Semaglutide$289 monthly · $169 effective monthly on the 12-month plan
  • Tirzepatide$359 monthly · $239 effective monthly on the 12-month plan

Before enrolling, confirm the billing interval, commitment, total charge, cancellation rule, dose policy, medication quantity, and whether any lab cost sits outside the plan. A lower effective monthly figure can reflect a longer prepaid obligation rather than a month-to-month rate.

Found sells a program, not only a vial

Found's official offer terms say its compounded GLP-1 plan includes a metabolic assessment, access to weight-loss medical providers, medication when prescribed, coaching, lifestyle tools, and community access. That combination is the central strength for a reader who will use the support.

The medication page also says prescriptions are discretionary and describes ongoing care-team messaging. The added services lose value if the customer only wants medication, so the right comparison is based on intended use rather than headline price alone.

Plan commitments and service complaints need scrutiny

Found's offer terms vary by enrollment date and plan, and its billing consent separates subscription, medication, and potential laboratory charges. Save the exact offer terms presented at checkout. Ask how cancellation affects prepaid service and any medication already in process.

Trustpilot and BBB contain mixed consumer reports. The recurring concerns worth checking involve billing, cancellation, support, and delivery, while favorable posts often discuss coaching or care-team interactions. These are anecdotal service signals. They cannot show how a medication will work for an individual or prove that every customer receives the same experience.

Clinical care and pharmacy fulfillment are distinct roles

Found presents its clinicians as the decision-makers for prescribing. Its medication page says compounded semaglutide is filled through licensed U.S. pharmacies and describes a pharmacy testing process. Those are company representations and should be verified for the pharmacy assigned to the actual prescription.

Ask for the medical group's identity, the prescriber's state license, the dispensing pharmacy, the compounded formulation, and a pharmacist contact. A statement about a pharmacy category is useful, but it does not replace checking the named facility and shipment.

Match the plan to the support you will actually use

Found's value proposition depends on engagement beyond receiving medication. Before choosing it, ask how often clinician follow-up occurs, whether coaching is scheduled or on demand, what messaging response window applies, and which services remain available if the medication changes. A member who will not use coaching, tools, or community access should compare the plan against a simpler medication-included alternative on both total cost and service burden.

The compounded and brand pathways also require different budgets. For a compounded plan, verify the formulation, quantity, pharmacy, supplies, and whether the amount changes as treatment changes. For a brand prescription, identify the separate membership, pharmacy price, insurance decision, prior-authorization support, and fallback if coverage is denied. Do not use a compounded-plan figure to predict the cost of Wegovy or Zepbound.

Save the offer version and billing interval shown at enrollment. Found's public terms distinguish members by enrollment date, and consumer complaints show why cancellation evidence matters. Record the cancellation confirmation, the status of any prescription already sent to a pharmacy, and the date service access ends. That creates a clearer test of whether the integrated program remains worth renewing.

Found is easiest to reject when the customer wants a short, transactional prescription service. Coaching, community, and app tools are substantive inclusions only for a member who uses them, while longer terms can trade flexibility for a lower effective rate. Ask what can be paused, which services continue between shipments, and whether changing medication changes the plan. If those answers add complexity without value, a narrower program is a better fit.

The review evidence is broad enough to be useful but still requires restraint. Trustpilot supplies a large exact-domain profile and BBB adds a separate complaint and review process. Both capture self-selected experiences, not a random patient sample, and neither verifies medication potency or prescribing quality. Their value is in the repeated operational questions they surface. The verdict remains tied to Found's documented bundle, the buyer's intended use of it, and the terms shown at enrollment.

Alternatives can be simpler or more insurance-focused

Choose a leaner medication-included provider if coaching and community features would go unused. Choose a brand-access service with explicit insurance support if coverage for Wegovy or Zepbound is the goal. Choose a local obesity-medicine practice when broader medical coordination and in-person follow-up outweigh home-delivery convenience.

Found is a credible shortlist candidate for the patient who wants its full support model and accepts the plan terms. It should not win on an effective monthly figure until the complete commitment and cancellation terms are understood.

How this review was prepared

We checked Found Health’s public pricing and programme pages on 29 August 2026. The review covers published pricing, plan terms, inclusions, and availability. It is not a rating, a clinical assessment, or a guarantee of eligibility or outcomes.

Evidence limits

  • Offer terms differ by enrollment date and selected plan; checkout controls the actual commitment.
  • The review does not name one pharmacy for every Found prescription.
  • Trustpilot and BBB reports are anecdotal service evidence, not representative clinical evidence.
  • Brand-name medication, insurance coverage, and laboratory costs require separate confirmation.